UNSPSC 51111858: Liarozole

This classification denotes a non-steroidal aromatase inhibitor with the molecular formula C17H13ClN4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K0Q29TGV9Y, chemically known as 1h-benzimidazole, 5-((3-chlorophenyl)-1h-imidazol-1-ylmethyl)- but generally known as liarozole, which bears US NIH Compound Identifier 60652. European Medicines Agency schedules Liarozole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14356MIG.

UNSPSC 51111858 Liarozole is a Commodity-level code for a retinoid compound used in dermatological treatment. State and local governments procure this pharmaceutical under the code primarily through health departments, public health agencies, and correctional facilities that provide medical services to inmates or vulnerable populations. The drug is typically sourced as a prescription medication for conditions such as ichthyosis and other keratinization disorders, and procurement occurs either through direct pharmacy acquisition or standing pharmaceutical supply agreements with state Medicaid programs and county health systems.

The source material contains no recent state or local contract opportunities posted under this code, and accordingly provides no data on issuing-body concentration, geographic distribution, or representative solicitations to evaluate.